In summary, the history of GLP-1 drugs is a remarkable journey from an obscure gut peptide to a cornerstone of modern metabolic therapy a journey marked by scientific ingenuity, translational research breakthroughs, and profound clinical benefit for millions of patients
In orforgliprons study, up to 10% of patients stopped treatment, compared with 3% on placebo
The team at IBI Wellness can help answer questions on semaglutide, how it works, and if you might be a candidate for GLP-1 medications
25+ Key Opinion Leaders (KOLs) were contacted for insights on Glucagon-like Peptide-1 (GLP-1) Agonists incorporation in the evolving treatment landscape, patient reliance on conventional therapies, patient therapy switching acceptability, drug uptake, along with challenges related to accessibility
Intended Use & Disclaimer
How does Mounjaro help with weight loss faster than Ozempic for some patients